Aemetis (NASDAQ:AMTX) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?

Aemetis, Inc (NASDAQ:AMTX) shares passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $2.09 and traded as low as $1.8110. Aemetis shares last traded at $1.82, with a volume of 474,057 shares trading hands.

Wall Street Analyst Weigh In

A number of research firms have commented on AMTX. Ascendiant Capital Markets lifted their target price on Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Wall Street Zen raised Aemetis from a “sell” rating to a “hold” rating in a report on Saturday, August 22nd. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $11.88.

Aemetis Stock Down 3.7%

The firm’s fifty day moving average price is $1.70 and its two-hundred day moving average price is $2.09. The stock has a market capitalization of $132.07 million, a PE ratio of -2.01 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.16. The company had revenue of $62.70 million during the quarter, compared to analysts’ expectations of $67.69 million. As a group, analysts predict that Aemetis, Inc will post -0.89 EPS for the current year.

Hedge Funds Weigh In On Aemetis

Institutional investors and hedge funds have recently modified their holdings of the company. Royal Bank of Canada increased its position in Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 8,825 shares during the last quarter. Creative Planning purchased a new position in Aemetis in the second quarter worth about $30,000. Virtu Financial LLC purchased a new position in Aemetis in the fourth quarter worth about $31,000. Sanctuary Advisors LLC bought a new stake in shares of Aemetis during the 1st quarter valued at about $33,000. Finally, HRT Financial LP bought a new stake in shares of Aemetis during the 4th quarter valued at about $36,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.